NASDAQ · Drug Manufacturers - Specialty & Generic

EMBC (EMBC) Stock

$5.69 +8.38% NASDAQ: EMBC Healthcare

Valuation

MetricValue
Price$5.69
Market Cap$337.57M
P/E Ratio3.33
P/B Ratio-0.47
P/S Ratio0.29
EPS (TTM)$1.62
52-Week High$15.55
52-Week Low$2.77
Dividend Yield0.81%

Financials & Margins

MetricValue
ROE-13.98%
ROA6.92%
ROCE29.93%
Gross Margin30.46%
Operating Margin30.46%
Net Margin8.59%
Debt/Equity-2.45
Current Ratio2.41

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.2B$1.1B$1.1B$1.1B$1.1B
Operating Profit$492.0M$378.0M$230.0M$174.0M$329.0M
Net Profit$415.0M$224.0M$70.0M$78.0M$95.0M
EPS$7.31$3.89$1.22$1.34$1.62
Op Margin42.2%33.5%20.5%15.5%30.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$788.0M$1.1B$1.2B$1.3B$1.1B
Total Liabilities$194.0M$2.0B$2.0B$2.0B$1.7B
Cash$0$331.0M$326.0M$268.0M$226.0M
Borrowings$4.0M$1.6B$1.6B$1.6B$1.4B

Latest News

Embecta (EMBC) Stock Fair Value Moves Lower As Analysts Reset Medtech Expectations Simply Wall St. · Jul 15, 2026 embecta appoints Nimish Muzumdar as SVP and President, North America GlobeNewswire · Jun 16, 2026 Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire · Jun 5, 2026 embecta to Participate in Investor Events GlobeNewswire · Jun 1, 2026 Embecta (EMBC) Hit With A Sharp Target Cut As Medtech Sentiment Weakens Insider Monkey · May 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$456.0M$412.0M$68.0M$36.0M$192.0M
Investing Cash Flow$-78.0M$-48.0M$-53.0M$-32.0M$-19.0M
Financing Cash Flow$-417.0M$-1.5B$-4.0M$-3.0M$-6.0M
Net Cash Flow$0$331.0M$-4.0M$-52.0M$-46.0M
Free Cash Flow$417.0M$388.0M$41.0M$20.0M$182.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.68
EV / EBITDA5.78
FCF Yield55.94%
Quick Ratio1.68
Interest Coverage2.62
Return 1Y-68.86%
Return 3Y-83.58%
Return 5Y—

Ownership

Insiders Held1.74%
Institutions Held100.57%
Institutions Float Held102.35%
Institutional HolderSharesReport Date
Blackrock Inc.9,167,2122026-03-31
Yacktman Asset Management Lp3,671,8772026-03-31
River Road Asset Management, LLC3,449,5022026-03-31
American Century Companies Inc3,439,5122026-03-31
Vanguard Capital Management LLC2,563,9512026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AQST $5.38 +2.67% -8.29 $675.01M 0.00%
CDNA $49.60 +1.29% 23.29 $2.57B 0.00%
EBS $6.46 +3.86% 8.67 $333.31M 0.00%
EVH $4.23 -1.17% -0.77 $475.79M 0.00%
MRVI $7.38 +1.10% -4.48 $2.04B 0.00%

About EMBC

EMBC is led by CEO Devdatt Kurdikar, employs 2,000 people, headquartered in US, publicly traded since 2022.

EMBC stock trades at $5.69 with a market capitalization of $337.57M. The stock is valued at a price-to-earnings (P/E) ratio of 3.33, price-to-book of -0.47, price-to-sales of 0.29. Over the past 52 weeks the stock has ranged between $2.77 and $15.55, and currently trades 63.4% below its 52-week high. It pays a dividend yielding 0.81%.

On profitability, EMBC generates a return on equity (ROE) of -13.98%, return on capital employed of 29.93%, an operating margin of 30.46%, a net profit margin of 8.59%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides